Annex 5 in the GPA means “Section D of Annex 17-A;”
Annex 5 in the GPA means “Schedule 2.C”;
Annex 5. Means proof of supplementary documentation considered relevant and material to the Agreement as detailed under Section-36 of the Agreement.
Examples of Annex 5 in a sentence
The addendum will include charge information of the type found in Annex 2, and LLFs as found in Annex 5.
When using the tables in Annex 5, reference should be made to the LLFC allocated to the MPAN to find the appropriate values.
This statement will be reissued with Annex 5 populated once the LLFs have been calculated and audited.
Further provisions with respect to the Council of Governors are set out in Annex 5.
The Templates approved by the Board (Annex 5 of the OPG, as amended in March 2016) do not include a separate template for project and programme concepts but provide that these are to be submitted using the project and programme proposal template.
More Definitions of Annex 5
Annex 5. For Export Bxxx Discount under L/C
Annex 5. Template Request for the interim payment (for all Selected Third Parties except SMEs) 31 ANNEX 6: Template Request for the final payment of the balance (for all Selected Third Parties except SMEs) 32
Annex 5 the minutes of the Shareholders' Meeting of 18th June 1997 as referred to in Article 7.10 of the Share Purchase Agreement;
Annex 5. Regulation xxxx://xxx- xxx.xxxxxx.xx/XxxXxxXxxx/xxxx/xx/xx/0000/x_000/x_00000000000xx00000000.xxx SIGNATURES AS WITNESS the Beneficiaries have caused this Consortium Agreement to be duly signed by the undersigned authorised representatives the day and year first above written. Signature: Name: Title: Date of Signature: ANNEX 1: List of Affiliates having access rights to project Foreground or Background
Annex 5. Press Releases TITLE: Standard Operating Procedure (“SOP”) regarding development and approval of Press Materials and Media Relations Activities (both as defined below) development between Sucampo Pharmaceuticals, Inc. (“SPI”), Takeda Pharmaceutical Company Limited (“TPC”) and TPC’s Affiliates, including Takeda Pharmaceuticals North America, Inc. (“TPNA”) (TPC and its Affiliates collectively “Takeda”) Effective Date: January 31, 2006 Supersedes: N/A VERSION: 1 PURPOSE: To establish the procedures between SPI and Takeda regarding the development and approval of Press Materials (as defined below) and Media Relations Activities (as defined below) and maintenance of the confidentiality of Confidential Information (including Proprietary Product Information) under the Collaboration and License Agreement between SPI and Takeda dated October 29, 2004 (“Collaboration and License Agreement’). Nothing contained in this SOP shall be deemed to modify or amend any provision of the Collaboration and License Agreement or the Agreement among SPI, Takeda and Sucampo AG dated October 29, 2004. RESPONSIBILITIES: Each company is responsible for ensuring that its own employees who are involved in developing Press Materials and participating in Media Relations Activities, and the employees of its Affiliates who are involved in developing Press Materials and participating in Media Relations Activities, read, understand and comply with this SOP.